Jun Zhu

17 articles listing Jun Zhu in Nature Communications, PNAS, Science Advances, Science, indexed by Paperzzz from Crossref and OSF.

  1. scProtoTransformer: Scalable reference mapping across molecules, cells, and donors Science Advances
  2. DNA-programmed galvanic Ostwald ripening in nanoparticle assemblies Nature Communications
  3. Indium-free perovskite/silicon tandem solar cells with tin oxide recombination layer and electrodes Science
  4. Targeting the DNA methylation–H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis PNAS
  5. Gene-in-gene coding generates dual-isoform Fha condensates to control type VI secretion system assembly Nature Communications
  6. Fully cove-edged bilayer nanographene with parallel displaced stacking Nature Communications
  7. Learning the PTM code through a coarse-to-fine mechanism-aware framework Nature Communications
  8. TMS5-mediated R-loop dynamics regulate thermosensitive fertility conversion in rice Nature Communications
  9. Hydrogen bonding mediated electron donor-acceptor acceptor catalysis in hydrosulfonylation and sulfonyl dehydrogenation of olefins Nature Communications
  10. Two-dimensional NIR-II AIE nanotheranostic probes with ultralarge Stokes shifts for surgical navigation and ablation of glioma Science Advances
  11. Probing hidden symmetry via nonlinear transport in an altermagnet candidate Ca3Ru2O7 Nature Communications
  12. Biradical-mediated synergistic electrocatalysis using metal-free redox molecular catalysts Nature Communications
  13. Nitric oxide promotes rapid development of motility to accelerate biofilm dispersal in Vibrio cholerae PNAS
  14. Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer Nature Communications
  15. Multiplexed self-adaptable Janus hydrogels rescue epithelial malfunction to promote complete trachea repair Nature Communications
  16. Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity Nature Communications
  17. Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial Nature Communications